AI Governance Is Becoming Healthcare’s Next Major Compliance Burden

By Gilda D’Incerti, Founder and CEO, PQE Group.

Healthcare organizations have rapidly adopted artificial intelligence across clinical decision support, diagnostics, revenue cycle management, and operational systems.

AI tools are now embedded across many hospital environments, promising better clinical outcomes, decreased administrative burden, and smarter use of healthcare data.

But as adoption accelerates, oversight continues advancing rapidly.

Regulators are increasingly scrutinizing how AI is developed, validated, and deployed in healthcare, making AI governance a new compliance focus for health system leaders. Healthcare executives and boards must urgently manage the operational, legal, and regulatory obligations that accompany AI adoption.

AI Is No Longer Solely an IT Decision

Historically, new technologies in healthcare have often been treated primarily as IT decisions. Artificial intelligence changes that dynamic. AI systems influence clinical decision making, patient risk scoring, workflow prioritization, and reimbursement. Their effect goes beyond technology deployment to clinical accountability along with regulatory oversight.

This shift demands comprehensive oversight.

Effective AI oversight now demands coordination across compliance, legal, clinical leadership, risk management, and IT teams. Health systems must begin asking foundational questions about the algorithms they deploy:

• How was the model trained and validated?
• What data sources were used, and are they representative of the patient population?
• How frequently should models be monitored or recalibrated?
• Who is accountable if AI recommendations influence clinical outcomes?

Without formal governance structures in place, health systems risk deploying tools they cannot fully explain or defend during regulatory review.

Regulators Are Catching Up

Oversight advances alongside AI adoption. In the United States, the FDA has already begun developing guidance frameworks for AI-enabled medical software and adaptive algorithms, signaling greater regulatory attention to the lifecycle management of AI systems.

This signals accountability for algorithm development, testing, monitoring, and documentation. This means AI systems may require similar documentation, validation, and performance monitoring as medical devices. Many hospitals lack readiness for this operational rigor.

The Hidden Operational Workload

One of the most common mistakes health systems make is underestimating the operational effort required to govern AI effectively. This includes committing time to oversight, establishing new processes, and allocating resources to promote ongoing compliance and risk mitigation.

Deploying an algorithm is only the starting point. Responsible AI programs require regular oversight, including:

• Algorithm validation and revalidation
• Bias monitoring and performance tracking
• Documentation of model training data and updates
• Clinical review and oversight structures
• Audit trails that support regulatory inspection

Each item needs dedicated governance and clear accountability. Without them, AI meant to improve efficiency can add complexity and risk.

AI Is Becoming Part of Clinical Infrastructure

Many healthcare leaders still view AI as a pilot initiative or innovation program. Increasingly, however, AI tools are becoming embedded within everyday clinical processes. If algorithms help determine triage priorities, diagnostic interpretation, or patient risk stratification, they effectively become part of the organization’s clinical infrastructure.

This reality heightens the stakes.

Boards and executives are realizing AI oversight is fundamental. As systems affect care and decisions, governance becomes a strategic and safety-critical responsibility.

Preparing for the Next Phase of AI Adoption

The next phase of AI adoption in healthcare may be defined less by technological capability and more by governance maturity.

Health systems that establish structured oversight programs early will be better able to scale innovation while continuing regulatory readiness.

Essential steps include:

• Setting up formal AI governance committees that include clinical, compliance, legal, and IT leaders
• Creating model validation and lifecycle management processes
• Deploying monitoring tools to evaluate accuracy and bias
• Developing documentation standards that support regulatory review
• Ensuring executive leadership and boards understand their oversight responsibilities

Organizations that move from reactive compliance to forward-looking governance will be better prepared for the emerging regulatory landscape in healthcare AI. AI is growing essential to healthcare delivery. Governance must evolve accordingly. Treating AI oversight as core compliance, not solely a technical matter, is vital to health innovation.